EA201001517A1 - Замещенные пиперидины в качестве терапевтических соединений - Google Patents

Замещенные пиперидины в качестве терапевтических соединений

Info

Publication number
EA201001517A1
EA201001517A1 EA201001517A EA201001517A EA201001517A1 EA 201001517 A1 EA201001517 A1 EA 201001517A1 EA 201001517 A EA201001517 A EA 201001517A EA 201001517 A EA201001517 A EA 201001517A EA 201001517 A1 EA201001517 A1 EA 201001517A1
Authority
EA
Eurasian Patent Office
Prior art keywords
therapeutic compounds
substituted piperidines
compounds
piperidines
substituted
Prior art date
Application number
EA201001517A
Other languages
English (en)
Inventor
Петер Херольд
Роберт Мах
Штефан Шутц
Винченцо Чинке
Александар Стояновиц
Дирк Бенке
Стьепан Елаковиц
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of EA201001517A1 publication Critical patent/EA201001517A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Описываются соединения общей формулы (I)и их фармацевтически приемлемые соли, в которых Rимеет определения, подробно проиллюстрированные в описании, в качестве ингибиторов β-секретазы, катепсина D, плазмепсина II и/или протеазы ВИЧ.
EA201001517A 2008-04-02 2009-04-01 Замещенные пиперидины в качестве терапевтических соединений EA201001517A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08153929 2008-04-02
PCT/EP2009/053898 WO2009121914A1 (en) 2008-04-02 2009-04-01 Substituted piperidines as therapeutic compounds

Publications (1)

Publication Number Publication Date
EA201001517A1 true EA201001517A1 (ru) 2011-04-29

Family

ID=40627638

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001517A EA201001517A1 (ru) 2008-04-02 2009-04-01 Замещенные пиперидины в качестве терапевтических соединений

Country Status (10)

Country Link
EP (1) EP2271644A1 (ru)
JP (1) JP2011516453A (ru)
KR (1) KR20110002459A (ru)
CN (1) CN101970431A (ru)
AU (1) AU2009232012A1 (ru)
BR (1) BRPI0910991A2 (ru)
CA (1) CA2719070A1 (ru)
EA (1) EA201001517A1 (ru)
MX (1) MX2010010876A (ru)
WO (1) WO2009121914A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011057160A2 (en) * 2009-11-06 2011-05-12 The Regents Of The Uiversity Of California Method to improve the immunogenicity of vaccine antigens by modification of cleavage sites in hiv-1 gp 120
BR112012008849A2 (pt) 2009-10-14 2015-09-22 Schering Corp composto, composição farmacêutica, e, uso de um composto
GB201008209D0 (en) * 2010-05-17 2010-06-30 Senexis Ltd Compounds
EP2771008A4 (en) 2011-10-28 2015-04-08 Merck Sharp & Dohme MACROCYCLES INCREASING P53 ACTIVITY AND USES THEREOF
BR112015013611A2 (pt) 2012-12-20 2017-11-14 Merck Sharp & Dohme composto, e, composição farmacêutica
CN105001300A (zh) * 2014-04-17 2015-10-28 复旦大学 组织蛋白酶d抑制剂及其制备方法、药物组合物和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1816122A3 (en) * 2006-01-19 2007-09-19 Speedel Experimenta AG 3,4,5-substituted piperidines as therapeutic compounds
EP1908761A1 (en) * 2006-10-04 2008-04-09 Speedel Experimenta AG Organic compounds
EP1911758A1 (en) * 2006-10-04 2008-04-16 Speedel Experimenta AG Phenyl piperidine derivatives for use as renin inhibitors

Also Published As

Publication number Publication date
MX2010010876A (es) 2010-10-26
CN101970431A (zh) 2011-02-09
WO2009121914A1 (en) 2009-10-08
EP2271644A1 (en) 2011-01-12
KR20110002459A (ko) 2011-01-07
AU2009232012A1 (en) 2009-10-08
BRPI0910991A2 (pt) 2016-01-19
JP2011516453A (ja) 2011-05-26
CA2719070A1 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
EA201070786A1 (ru) Бензофуропиримидиноны
EA201001359A1 (ru) Гетероциклические соединения в качестве ингибиторов cxcr2
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
EA200870217A1 (ru) 4-арил-2-аминопиримидины или 4-арил-2-аминоалкилпиримидины в качестве модуляторов jak-2 и содержащие их фармацевтические композиции
EA201200550A1 (ru) Фармацевтические композиции, включающие bi-1356 и метформин
CO6511251A2 (es) Compuestos quimicos
UY30500A1 (es) Compuestos de azabencimidazolilo
EA201200631A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
EA201100992A1 (ru) Карбазолкарбоксамидные соединения, применимые в качестве ингибиторов киназы
EA200970805A1 (ru) Ингибиторы серинпротеаз для лечения hcv инфекций
ATE461202T1 (de) Hiv-integrasehemmer
EA201200049A1 (ru) 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17
UY30600A1 (es) Compuestos novedosos
ECSP10010722A (es) Compuestos orgánicos
UA106748C2 (ru) Производные пролина как ингибиторы катепсина
EA200801199A1 (ru) Ингибиторы киназы
NO20091395L (no) Nye tiofenderivater
EA200901124A1 (ru) Соединения формулы (i) в качестве ингибиторов серинпротеазы
EA201490596A1 (ru) Новые производные дигидрохинолин-2-она
ATE495176T1 (de) Spiroindolinon-derivate
EA201270590A1 (ru) Ингибиторы акт
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
EA200801413A1 (ru) Гетероциклические сетр ингибиторы
ATE531721T1 (de) Cyanoaminochinolone als gsk-3-inhibitoren